We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions! Looking forward to Rome! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @nihalolcaydogan.bsky.social @hih-tuebingen.bsky.social

Now Surender Surender on stage, presenting our data on CDK4/6 inhibition in experimental glioma! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hih-tuebingen.bsky.social

Great talk by @ghtabatabai.bsky.social about time management in academia @eanoassociation.bsky.social

Great poster session with nice discussions about our current work! @eanoassociation.bsky.social @ghtabatabai.bsky.social @hannes-becker1996.bsky.social @nihalolcaydogan.bsky.social @hih-tuebingen.bsky.social

Nice opportunity to present our data on regorafenib in combination with navitoclax at @eanoassociation.bsky.social @hannes-becker1996.bsky.social @ghtabatabai.bsky.social

Just happening. Max Niyazi on stage at EANO 2025 👍🏼💡

Great comprehensive talk by @ghtabatabai.bsky.social to give insights into CRISPR screen. More to come! @eanoassociation.bsky.social

🧠 Just published in Neuro-Oncology: A comprehensive consensus review by @neuroonc.bsky.social and EANO on current management and future directions in adult #Glioblastoma care. Explore key recommendations and research priorities. 🔗 academic.oup.com/neuro-oncolo... #NeuroOncology

🚨 At #EANO2025, we already expect more than 1,200 participants! Don’t miss out on this fantastic experience to meet experts in the field of #NeuroOncology from all over the world. Registration is still open eano.eu/eano2025/ We can’t wait to see you in #Prague!

🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice. 🔗 academic.oup.com/neuro-oncolo...

Innovative trial design, thank you for the opportunity for being part of it!

Extremely happy that we could have contributed!

Thank you for having the opportunity to present our data at this year DGNC in Hanover. #DGNC2025

Almost 25 year old T-shirt, reminds me of great experience at MGH/HMS 2000/2001, @harvard.edu - hard to see this institution under pressure now, and impressed by the integrity and resilience of Harvard leadership (more on LinkedIn) 🙌 #Harvard #AcademicFreedom #ScienceForDemocracy #ScienceMatters

Happy to represent Tuebingen in this initiative! #aufstehenfuerdemokratie

Tübingen 12 Feb 2025 Geschwister Scholl Platz Democracy needs facts Science needs Democracy. #aufstehenfuerdemokratie

We are more than happy that our publication "The Immunopeptidomic Landscape of Ependymomas Provides Actionable Antigens for T Cell-Based Immunotherapy" is accepted by Neurooncology Advances. academic.oup.com/noa/advance-... Check it out ;) @unituebingen.bsky.social @hih-tuebingen.bsky.social

👍 Herzlich Willkommen auf dem Bluesky-Account der #unituebingen. Wir posten ab sofort hier und auf unseren anderen Kanälen, z.B. Instagram, Facebook, LinkedIn, Mastodon. Unsere Aktivitäten auf X haben wir beendet.

Happy to see this finally out after a long team effort! 🎉🎉🎉 @hih-tuebingen.bsky.social @ghtabatabai.bsky.social

Merry Christmas and very best wishes für 2025! @hih-tuebingen.bsky.social @unituebingen.bsky.social @neurooncotue.bsky.social

New insights into #meningiomas, with The Brain Tumour Charity’s funding and led by @gelarehzadeh.bsky.social, has been included in their #Research Highlights of 2024. Read more about it here: www.thebraintumourcharity.org/news/researc...

Two flagship chair professorships for neurodgenerative diseases in Tübingen, Germany. Both affiliated with our university @hih-tuebingen.bsky.social and the German Center for Neurodegenerative diseases @dzne.science. Apply and join us! www.nature.com/naturecareer... www.nature.com/naturecareer...

📢The Faculty of Medicine at the University of Tübingen invites applications for a position at the Hertie Center for Neurology for an Endowed #Professorship (W3) in #Neurology with a Focus on #Neurodegenerative #Diseases, available by 1 October 2026, potentially earlier Full PDF: tinyurl.com/y6bfky83

@ghtabatabai is a neurologist and a physician scientist at the University of Tübingen and the Managing Director Neurology at the University Hospital Tübingen. Her research includes target discovery & validation, molecular mechanisms of treatment resistance, & novel delivery routes to brain tumors.

Just happening in Tübingen: Great talk by Prof Ulrich Dirnagl on Research Integrity 🙌💡👍🏼 @hih-tuebingen.bsky.social

Great to see this finally out!

Treatment of glioblastoma patients with personalized vaccines outside clinical trials: Lesoons ignored? academic.oup.com/neuro-oncolo...